Top 10 Later Stage Lead Investors: Healthcare Software & Services Technology
| Rank | Investor Name |
|---|---|
| 1 | General Catalyst |
| 2 | Ally Bridge Group |
| 3 | US Venture Partners |
| 4 | OAK HC/FT |
| 5 | Aaron Perman |
| 6 | RA Capital Management |
| 7 | New Enterprise Associates |
| 8 | Khosla Ventures |
| 9 | Goldman Sachs Asset Management |
| 10 | Questa Capital |
Administrative automation and AI documentation tools are the entry points for most new healthcare software investment. These firms are ranked by rounds led rather than participation, so this is the short list of investors actually pricing later stage deals in the category.
The CapitalDart directory identifies the right person to contact at each of these firms, with their individual investment criteria.
Create a free account and get the contacts for the investors above.
Rankings reflect investment activity from January 2025 through July 2026 in US and Canada companies, based on transactions matched to the CapitalDart directory. Seed and Early Stage rank by participation, Later Stage by rounds led, Private Equity by control and buyout activity. Updated periodically.